BOSTON & OAKDALE, Minn.--(BUSINESS WIRE)--Pace Analytical Services, LLC today announced the acquisition of Wolfe Laboratories, Inc., a leading translational contract drug development company in the Boston area. The combined capabilities of the two organizations now offer the life science industry a one-stop-shop providing formulation, process development, and analytical and CMC testing for complex molecules, from discovery through Phase 3 development and post approval. Financial terms of the transaction were not disclosed.
“Wolfe Laboratories brings a whole new synergistic dimension to our life science analytics business, providing expertise in new, exciting and complex molecules in the pipelines today,” commented Greg Kupp, Vice President and COO of Pace Analytical Life Sciences. “Its reputation as the partner of choice for the most advanced and cutting-edge drug modalities reinforces Pace’s mission of providing solutions that bring real value to clients. We welcome Janet and her highly respected scientific teams to the Pace family.”
“This partnership with Pace provides us with the resources to grow and meet the expanding needs of our amazing group of biopharmaceutical and pharmaceutical customers as we are now able to provide end-to-end support, from early stage CMC development to post commercialization GMP testing on oligonucleotides, biologics, and small molecules,” commented Janet Wolfe, Founder of Wolfe Laboratories.
About Wolfe Laboratories
Wolfe Laboratories is a premier contract research organization that provides integrated drug development solutions to the biopharmaceutical industry. Wolfe Laboratories is an essential element of the drug development ecosystem, recognized by global and virtual biopharmaceutical companies as a science-driven organization whose mission is to provide outstanding discovery and development services tailored to its clients’ needs for rational formulation development. Wolfe Laboratories integrates the critical path components of early development to ensure that programs advance while meeting rigorous scientific demands with flexibility to address dynamic challenges and aggressive timelines. Wolfe Laboratories’ vision is to improve human health, and we continue to strive towards that goal by embracing our core values of integrity, excellence and teamwork. The company has a high percentage of repeat clients, which is a testament to its long-term commitment of continual investment in its capabilities to meet biopharma's growing demand for high quality, integrated early development services. Founded in 1999, the company is located in Woburn, MA. www.wolfelabs.com
About Pace Analytical Life Sciences
Pace Analytical Life Sciences, a subsidiary of Pace Analytical Services, LLC is a network of full-service contract development and analytical testing laboratories providing formulation, CMC, process development, chemistry and microbiology testing services to the Pharmaceutical, Biopharmaceutical, Medical Device, and combination product industries. Our investment in state-of-the-art facilities and highly trained personnel emphasizes our commitment to delivering positive customer experiences across all channels of our business. We are dedicated to providing not only the best in development and analytical testing services, but also the most reliable. We are well-equipped to handle almost any project regardless of scope or complexity with facilities in Oakdale, Minnesota, San German, Puerto Rico, Somerset, New Jersey, and in Boston, Massachusetts under our subsidiary, Wolfe Laboratories. Pace Analytical Services is the largest, American-owned environmental testing company in the United States, headquartered in Minneapolis, MN. Pace also provides scientific workflow solutions to in-house R&D labs including staffing, regulatory consulting and equipment support services.